AdvanTx Support
Projects or ideas that are deemed to have significant potential will receive the following benefits:
- Mentorship: Scientific support will be provided to develop a therapeutic target concept or project.
- Translation: Support will be provided to access and coordinate resources and funding through UNC and external organizations.
- Commercial Assessment: When applicable, engage with key potential stakeholders on campus and externally to obtain feedback and assess market potential.
Therapeutic Protein or Gene
AdvanTx Support
Therapeutic Mentorship
- Develoment of therapeutic hypothesis
- Human translational data
- Technical feasibility
- Preclinical tools & reagents
- Safety assessment
- Clinical development strategy & patient selection
- Competitive Analysis
- Project de-risking
- Therapeutic Workplan Development
Translation
- UNC School of Pharmacy: Eshelman Institute for Innovation
- UNC Lineberger Cancer Center
- UNC School of Medicine Pilot Awards
- NC TraCS
- UNC OTC Grants
- UNC Idea Grants
- NIH/NSF
- NC Biotech Center
- Pinnacle Hill
- Foundations
Drug Discovery Research Plan & Budget to IND
 Lead Identification 1 year, $2 – $4M |
 Lead Optimization 1-2 years, $3 – $5M |
Development Candidate Selection <1 year, $1.5 – 2.5M |
GLP studies & IND Prep/filing for Phase 1 1 year, $1.5 – $2.5M |
 |
|||||
|---|---|---|---|---|---|---|---|---|---|
|
Medchem
|
|||||||||
|
Biophysical & Biochemical assay screening
|
|||||||||
|
In vitro ADME
|
|||||||||
|
Cellular assay screening
|
|||||||||
|
In vivo DMPK
|
|||||||||
|
Selectivity screening
|
Broad selectivity
|
||||||||
|
In vivo screening
|
PK/PD
|
Clinical TE assay
|
|||||||
|
IP filing
|
GLP Tox
|
||||||||
|
Developability/Formulation
|
GLP Safety Pharm
|
||||||||
|
Non-GLP Scale Up, API Prep & CMC
|
GLP Genetox
|
||||||||
|
Acute & Chronix Tox
|
GLP hERG
|
||||||||
|
Additional DMPK
|
|||||||||
|
IND Prep
|
|||||||||
|
Target validated & Hit ID
|
Chemical matter ID
|
Precandidate ID
|
Development Candidate ID
|
IND Ready
|
|||||